P/E ratio for Axonics Modulation Tech (AXNX)
P/E ratio as of June 2024 (TTM): -270
According to Axonics Modulation Tech's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -269.6. At the end of 2022 the company had a P/E ratio of -48.1.
P/E ratio history for Axonics Modulation Tech from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -48.1 | 61.48% |
| 2021 | -29.8 | -10.5% |
| 2020 | -33.3 | 235.08% |
| 2019 | -9.93 | 6.35% |
| 2018 | -9.34 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 PAVmed
PAVM | -0.9127 | -99.66% | 🇺🇸 USA |
 Philips PHG | -36.0 | -86.65% | 🇳🇱 Netherlands |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.